JP2008504236A - Ｆｇｆｒ結合性ペプチド - Google Patents

Ｆｇｆｒ結合性ペプチド Download PDF

Info

Publication number
JP2008504236A
JP2008504236A JP2007515781A JP2007515781A JP2008504236A JP 2008504236 A JP2008504236 A JP 2008504236A JP 2007515781 A JP2007515781 A JP 2007515781A JP 2007515781 A JP2007515781 A JP 2007515781A JP 2008504236 A JP2008504236 A JP 2008504236A
Authority
JP
Japan
Prior art keywords
peptide sequence
fgfr
peptide
amino acid
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007515781A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008504236A5 (pt-PT
Inventor
エリザベート・ボック
ウラディミール・ベレジン
Original Assignee
エンカム ファーマシューティカルズ アクティーゼルスカブ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エンカム ファーマシューティカルズ アクティーゼルスカブ filed Critical エンカム ファーマシューティカルズ アクティーゼルスカブ
Publication of JP2008504236A publication Critical patent/JP2008504236A/ja
Publication of JP2008504236A5 publication Critical patent/JP2008504236A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Psychology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2007515781A 2004-06-18 2005-06-17 Ｆｇｆｒ結合性ペプチド Pending JP2008504236A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200400963 2004-06-18
PCT/DK2005/000400 WO2005123759A2 (en) 2004-06-18 2005-06-17 Fgfr binding peptides

Publications (2)

Publication Number Publication Date
JP2008504236A true JP2008504236A (ja) 2008-02-14
JP2008504236A5 JP2008504236A5 (pt-PT) 2008-08-07

Family

ID=35510321

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007515781A Pending JP2008504236A (ja) 2004-06-18 2005-06-17 Ｆｇｆｒ結合性ペプチド

Country Status (11)

Country Link
US (1) US20090074774A1 (pt-PT)
EP (1) EP1765861B1 (pt-PT)
JP (1) JP2008504236A (pt-PT)
CN (1) CN101027320A (pt-PT)
AT (1) ATE545655T1 (pt-PT)
AU (1) AU2005254613A1 (pt-PT)
BR (1) BRPI0512254A (pt-PT)
CA (1) CA2570267A1 (pt-PT)
MX (1) MXPA06014804A (pt-PT)
WO (1) WO2005123759A2 (pt-PT)
ZA (1) ZA200610546B (pt-PT)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1886422A (zh) * 2003-09-30 2006-12-27 恩卡姆医药公司 调节细胞存活、分化和/或突触可塑性的方法
EP2412727B1 (en) 2006-02-14 2016-06-29 University Of Tasmania Through The Menzies Research Institute Metallothionein-derived peptide fragments
WO2007110079A2 (en) * 2006-03-29 2007-10-04 Enkam Pharmaceuticals A/S Targeted delivery of fgfr ligands into the brain
CN101619093B (zh) * 2009-05-26 2011-12-07 中国人民解放军第三军医大学野战外科研究所 具有促进成纤维细胞生长因子受体3活性的多肽及其筛选方法和应用
EP2483407A2 (en) 2009-09-30 2012-08-08 President and Fellows of Harvard College Methods for modulation of autophagy through the modulation of autophagy-enhancing gene products
ES2673872T3 (es) 2012-06-05 2018-06-26 The Board Of Trustees Of The Leland Stanford Junior University Mimético del péptido NCAM para su uso en el tratamiento de trastorno de depresión mayor
CN109867724B (zh) * 2019-04-19 2020-09-15 温州医科大学 一种fgfr抗体及其在脊髓损伤治疗中的用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003016351A2 (en) * 2001-08-17 2003-02-27 Enkam Pharmaceuticals A/S N - cam related compounds modulating cell groth

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036945A (en) * 1976-05-03 1977-07-19 The Massachusetts General Hospital Composition and method for determining the size and location of myocardial infarcts
US4331647A (en) * 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US4599311A (en) * 1982-08-13 1986-07-08 Kawasaki Glenn H Glycolytic promotersfor regulated protein expression: protease inhibitor
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5693488A (en) * 1994-05-12 1997-12-02 The Rockefeller University Transmembrane tyrosine phosphatase, nucleic acids encoding the same, and methods of use thereof
US20020104122A1 (en) * 1994-06-17 2002-08-01 Kirin Beer Kabushiki Kaisha Methods for producing a plant with enhanced resistance to pathogenic fungi
EP2275551B1 (en) * 1999-10-29 2015-04-08 Novartis Vaccines and Diagnostics S.r.l. Neisserial antigenic peptides
GB0014870D0 (en) * 2000-06-16 2000-08-09 King S College London Peptides
WO2005049641A2 (en) * 2003-11-21 2005-06-02 Ace Biosciences A/S Surface-located campylobacter jejuni polypeptides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003016351A2 (en) * 2001-08-17 2003-02-27 Enkam Pharmaceuticals A/S N - cam related compounds modulating cell groth
JP2005510463A (ja) * 2001-08-17 2005-04-21 エンカム ファーマシューティカルズ アクティーゼルスカブ 細胞の分化、増殖、再生、可塑性及び生存に影響を及ぼすことができる化合物

Also Published As

Publication number Publication date
CN101027320A (zh) 2007-08-29
ATE545655T1 (de) 2012-03-15
EP1765861B1 (en) 2012-02-15
CA2570267A1 (en) 2005-12-29
BRPI0512254A (pt) 2008-02-19
EP1765861A2 (en) 2007-03-28
WO2005123759A2 (en) 2005-12-29
WO2005123759A3 (en) 2006-05-04
MXPA06014804A (es) 2007-03-23
ZA200610546B (en) 2008-06-25
AU2005254613A1 (en) 2005-12-29
WO2005123759A8 (en) 2006-03-09
US20090074774A1 (en) 2009-03-19

Similar Documents

Publication Publication Date Title
US8008259B2 (en) Neurotrophin-derived peptide sequences
US8637465B2 (en) Fibroblast growth factor receptor-derived peptides binding to NCAM
US8329652B2 (en) Neuritogenic peptides
JP2008504236A (ja) Ｆｇｆｒ結合性ペプチド
US20090221506A1 (en) Gdnf derived peptides
JP2009511613A (ja) 神経細胞接着分子ｌ１のペプチド断片を含む新規ｆｇｆ受容体結合化合物
US20080226639A1 (en) Heparin Binding Peptide
US20150252075A1 (en) Neuroplastin derived peptides
WO2008022645A2 (en) Ncam fibronectin type 3 binding peptides
US20100168382A1 (en) Neuroplastin derived peptides
JP2009511614A (ja) 繊維芽細胞成長因子受容体誘導ペプチド
JP2015163616A (ja) Ｎｃａｍに結合する線維芽細胞増殖因子レセプター由来ペプチド
WO2009100724A1 (en) Novel peptide derived from ncam (bcl)
WO2008086813A2 (en) Peptides derived from proteins of the insulin super-family

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080616

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080616

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110125

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20111101